SEC 13F Intelligence

S. Muoio & Co. LLC / TREUR

S. Muoio & Co. LLC’s Trillium Therapeutics Inc Position

Does S. Muoio & Co. LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 160.0K shares worth $3M in Q3 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$3M
Q3 2021
Shares
160.0K
% of Portfolio
+2.16%
Quarters Held
1
position exited

Position History TREUR

Reported value by quarter
Q3 ’21: $3MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021160.0K$3M+2.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See S. Muoio & Co. LLC’s full portfolio or all institutional holders of TREUR.